Astrazeneca (AZN) Asset Utilization Ratio (2009 - 2026)

Astrazeneca has reported Asset Utilization Ratio for 18 years, with the latest figure at 0.53 in Q2 2026.

• On a quarterly basis, Asset Utilization Ratio rose 4.95% year-over-year to 0.53 in Q2 2026; TTM through Jun 2026 was 0.53, a 4.95% increase from a year earlier, with the FY2025 full-year figure at 0.54, up 3.78% from the prior year.
• Asset Utilization Ratio was 0.53 for Q2 2026 at Astrazeneca, up from 0.53 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.68 in Q3 2024, with the low at 0.4 in Q1 2022.
• Average Asset Utilization Ratio over 5 years is 0.52, with a median of 0.51 recorded in 2024.
• The sharpest annual moves came in 2024 and 2025: Asset Utilization Ratio jumped 50.79% in 2024, then retreated 26.23% in 2025.
• Over 5 years, Asset Utilization Ratio stood at 0.46 in 2022, then jumped by 42.01% to 0.66 in 2023, then declined by 22.75% to 0.51 in 2024, then gained by 0.88% to 0.51 in 2025, then rose by 3.89% to 0.53 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.53 (Q2 2026), 0.53 (Q1 2026), and 0.51 (Q4 2025), per Business Quant data.